Standard strategies for diagnosis and treatment of patients with newly diagnosed Parkinson disease
FRANCE
Citation Manager Formats
Make Comment
See Comments

Article Information
- First Published December 9, 2013.
Author Disclosures
- François Tison, MD, PhD and
- Wassilios G. Meissner, MD, PhD
- François Tison, MD, PhD and
(1)Novartis, (2)Boehringer-Ingelheim, (3) GlaxoSmithKline, (4) ABBOTT, (5) UCB
NONE
(1) Lundbeck, (2) Novartis, (3) UCB, (4) TEVA
NONE
NONE
NONE
NONE
(1) Addex pharma
NONE
NONE
NONE
(1) Novartis
(1) French Ministry of Health PHRC 2011, PI
(1) University Hospital Bordeaux
(1) Michael J. Fox Foundation
NONE
NONE
NONE
NONE
NONE
NONE
- Wassilios G. Meissner, MD, PhD
ANM GmbH, Cologne, Germany (2012); Novartis France
NONE
Speaking fees from Novartis, TEVA Lundbeck, ExpressionSantÏ¿½ and UCB; travel grants from Novartis, GSK, UCB andTEVA/Lundbeck
Journal of Neural Transmission, member editorial board
NONE
NONE
NONE
NONE
Speaking fees from Novartis, TEVA Lundbeck, ExpressionSantÏ¿½ and UCB; travel grants from GSK, Novartis, UCB andTEVA/Lundbeck
NONE
NONE
Unrestricted research grants from Novartis, TEVA/Lundbeck
French Ministry of Health, University Hospital Bordeaux,PSP-France and APTES
University Hospital Bordeaux and University Bordeaux
Michael J Fox Foundation
NONE
NONE
NONE
NONE
NONE
NONE
- for the French Parkinson's Disease Expert Centers; Service de Neurologie, CHU de Bordeaux, Pessac, France; Université de Bordeaux, Institut des Maladies Neurodégénératives, Bordeaux, France:
- Correspondence to:
francois.tison{at}chu-bordeaux.fr
Article usage
The Nerve!: Rapid online correspondence
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Related Articles
- No related articles found.